In the late 1990s, University of Kentucky Professor Douglas Andres found that mutations in a protein known as RIT1 could initiate cancer development in laboratory models. RIT1 works as a molecular switch. In response to signals from outside the cell, it turns on fundamental cellular activities, and then turns them off again to ensure they don’t continue unchecked.

Doug Andres team